Neoadjuvant long-course chemoradiotherapy for rectal cancer : does time to surgery matter?

作者: Ioanna G. Panagiotopoulou , Deepak Parashar , Eyas Qasem , Rasha Mezher-Sikafi , Jitesh Parmar

DOI: 10.9738/INTSURG-D-14-00192.1

关键词:

摘要: The objective of this paper was to evaluate whether delaying surgery following long-course chemoradiotherapy for rectal cancer correlates with pathologic complete response. Pre-operative (CRT) is standard practice in the UK management locally advanced cancer. Optimal timing CRT still not clearly defined. All patients a diagnosis who had undergone prior between January 2008 and December 2011 were included. Statistical analysis performed using Stata 11. Fifty-nine received selected period. Twenty-seven percent (16/59) showed histopathologic response 59.3% (35/59) tumor down-staging from radiologically-assessed node positive histologically-proven negative disease. There no statistically significant delay after completion 16 (CR) compared rest group [IR: incomplete response; CR median: 74.5 days (IQR: 70-87.5) IR 72 57-83), P = 0.470]. Although predictors either or nodal status identified logistic regression analyses, trend toward seen longer CRT.

参考文章(21)
Yves Francois, Chantal J. Nemoz, Jacques Baulieux, Jacques Vignal, Jean-Paul Grandjean, Christian Partensky, Jean Christophe Souquet, Patrice Adeleine, Jean-Pierre Gerard, Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial Journal of Clinical Oncology. ,vol. 17, pp. 2396- 2396 ,(1999) , 10.1200/JCO.1999.17.8.2396
R.J Heald, R.D.H Ryall, Recurrence and survival after total mesorectal excision for rectal cancer. The Lancet. ,vol. 327, pp. 1479- 1482 ,(1986) , 10.1016/S0140-6736(86)91510-2
Anne-Marie Mandard, Frédéric Dalibard, Jean-Claude Mandard, Jacques Marnay, Michel Henry-Amar, Jean-François Petiot, Alain Roussel, Jacques-Henry Jacob, Philippe Segol, Guy Samama, Jean-Marie Ollivier, Sylvie Bonvalot, Marc Gignoux, Pathologic Assessment of Tumor Regression After Preoperative Chemoradiotherapy of Esophageal Carcinoma. Clinicopathologic Correlations Cancer. ,vol. 73, pp. 2680- 2686 ,(1994) , 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
Seung-Gu Yeo, Dae Yong Kim, Tae Hyun Kim, Hee Jin Chang, Jae Hwan Oh, Won Park, Doo Ho Choi, Heerim Nam, Jun-Sang Kim, Moon-June Cho, Jong Hoon Kim, Jin-hong Park, Min Kyu Kang, Woong Sub Koom, Jae-Sung Kim, Taek-Keun Nam, Eui Kyu Chie, Jung Soo Kim, Kyung-Ja Lee, Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Annals of Surgery. ,vol. 252, pp. 998- 1004 ,(2010) , 10.1097/SLA.0B013E3181F3F1B1
Calogero Cammà, Marco Giunta, Francesco Fiorica, Luigi Pagliaro, Antonio Craxì, Mario Cottone, Preoperative Radiotherapy for Resectable Rectal Cancer JAMA. ,vol. 284, pp. 1008- 1015 ,(2000) , 10.1001/JAMA.284.8.1008
David E. Stein, Najjia N. Mahmoud, Pramila Rani Anné, Deborah G. Rose, Gerald A. Isenberg, Scott D. Goldstein, Edith Mitchell, Robert D. Fry, Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Diseases of The Colon & Rectum. ,vol. 46, pp. 448- 453 ,(2003) , 10.1007/S10350-004-6579-0
Jürgen Dunst, Thomas Reese, Thomas Sutter, Helmut Zühlke, Axel Hinke, Katrin Kölling-Schlebusch, Stefan Frings, Phase I Trial Evaluating the Concurrent Combination of Radiotherapy and Capecitabine in Rectal Cancer Journal of Clinical Oncology. ,vol. 20, pp. 3983- 3991 ,(2002) , 10.1200/JCO.2002.02.049
C.S Lim, B.J Mehigan, J.E Hartley, J.R.T Monson, Neoadjuvant therapy in the treatment of high risk rectal carcinoma Surgical Oncology-oxford. ,vol. 8, pp. 1- 11 ,(1999) , 10.1016/S0960-7404(99)00017-1